Langoyan, Melisa .
HRN: 05-35-28 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
CEFUROXIME 500MG (TAB)
01/04/2023
01/11/2023
PO
500mg
Q12H
UTI
Waiting Final Action